在抗瘤免疫期间CD73和腺在CD8+T细胞耗尽中的对比功能
Juan Saavedra-Almarza1, Solange Gouët1, Felipe Malgue1
1Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
Oncoimmunology
|March 13, 2026
概括
CD73促进T细胞疲分化,而腺A2A受体信号维持瘤中的前体耗尽的T细胞. 这说明了CD73/腺轴在T细胞耗尽和抗PD-1治疗中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- T细胞生物学T细胞生物学
背景情况:
- T细胞疲劳,T细胞功能衰退的状态,是由慢性抗原暴露和瘤微环境信号驱动的.
- 前体耗尽的T细胞 (Tpex) 是一种自我更新的细胞群,对于抗PD-1疗法中的T细胞增殖至关重要.
- 瘤微环境中的Tpex/Tex分化中CD73/腺酸轴的作用尚不清楚.
研究的目的:
- 研究CD73/腺轴在CD8+T细胞耗尽和Tpex/Tex分化中的作用.
- 阐明CD73缺乏和腺受体A2A (A2AR) 信号对T细胞耗尽动态的影响.
主要方法:
- 利用一个体外模型来检测CD8+T细胞的消耗.
- 使用CD73缺乏的OT-I细胞 (OT-I/CD73KO) 进行功能和转录组分析 (RNA-seq).
- 进行了体内研究,涉及T细胞转移到携带瘤的小鼠和A2AR阻断.
主要成果:
- 在Tpex形成期间CD73表达增加,与Tex生成负相关.
- CD73 缺陷影响了T细胞激活和向Tex的进展,促进了更像干细胞的转录组形状.
- 氨酸A2AR信号支持Tpex维护,而A2AR阻断在体内增强了Tex分化.
结论:
- CD73促进前体耗尽的T细胞 (Tpex) 分化为耗尽的T细胞 (Tex).
- 氨酸A2AR信号传输在维持瘤微环境中的Tpex种群方面发挥着至关重要的作用.
- 了解CD73/腺轴为增强抗瘤T细胞反应提供了潜在的治疗策略.
相关概念视频
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K


